Literature DB >> 19495791

RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.

Tadao Nakazawa1, Shin-ichi Murata, Tetsuo Kondo, Dongfeng Niu, Kunio Mochizuki, Tomonori Kawasaki, Tetsu Yamane, Nobuki Nakamura, Ryohei Katoh.   

Abstract

RET rearrangements (RET/PTC) is a major genetic alteration in papillary thyroid carcinomas. However, the prevalence of RET/PTC differs considerably among investigators, and its impact on cancer progression has been controversial. In the current study, we applied interphase fluorescence in situ hybridization (FISH) to touch imprint cytology of 14 papillary thyroid carcinomas along with reverse-transcription polymerase chain reaction (RT-PCR) analysis. FISH DNA probes included RET locus, and PCR primers were designed targeting RET/PTC1 or RET/PTC3. Split FISH signals of RET was observed in 78.6% (11/14) of tumors. Proportions of tumor cells having split RET signals ranged from 1.8% to 19.6% (mean 9.7%) in those 11 tumors. In RT-PCR analysis, RET/PTC was found in 28.6% (4/14) of tumors. Among tumors with split RET signals, 36.4% (4/11) of tumors exhibited detectable messenger RNA of RET/PTC1 or RET/PTC3. The remaining seven tumors with split RET signals had no RET/PTCs amplicon. In conclusion, the current study disclosed that RET/PTCs occur in a small population of tumor cells in papillary thyroid carcinomas. Even though RET/PTC is a specific genetic event in the carcinomas, our results suggested the possibility of RET/PTC as "passenger" abnormalities rather than "driver" oncogenic mutation during thyroid cancer progression, warranting further studies on mechanisms and implication of RET gene instability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495791     DOI: 10.1007/s00428-009-0789-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

Review 1.  GDNF family neurotrophic factor signaling: four masters, one servant?

Authors:  M S Airaksinen; A Titievsky; M Saarma
Journal:  Mol Cell Neurosci       Date:  1999-05       Impact factor: 4.314

2.  Cancer: drivers and passengers.

Authors:  Daniel A Haber; Jeff Settleman
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

3.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.

Authors:  R Cinti; L Yin; K Ilc; N Berger; F Basolo; S Cuccato; R Giannini; G Torre; P Miccoli; P Amati; G Romeo; R Corvi
Journal:  Cytogenet Cell Genet       Date:  2000

5.  RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

Authors:  Tadao Nakazawa; Tetsuo Kondo; Yoshihiko Kobayashi; Noboru Takamura; Shin-ichi Murata; Kaori Kameyama; Akira Muramatsu; Kohichi Ito; Makio Kobayashi; Ryohei Katoh
Journal:  Cancer       Date:  2005-09-01       Impact factor: 6.860

6.  Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

Authors:  Zhaowen Zhu; Raffaele Ciampi; Marina N Nikiforova; Manoj Gandhi; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

7.  Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.

Authors:  Christy M Caudill; Zhaowen Zhu; Raffaele Ciampi; James R Stringer; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

8.  Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.

Authors:  Kristian Unger; Horst Zitzelsberger; Giuliana Salvatore; Massimo Santoro; Tatjana Bogdanova; Herbert Braselmann; Peter Kastner; Lyudmilla Zurnadzhy; Nikolay Tronko; Peter Hutzler; Gerry Thomas
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

Review 9.  Functional genomics of cancer.

Authors:  Edison T Liu
Journal:  Curr Opin Genet Dev       Date:  2008-08-28       Impact factor: 5.578

Review 10.  RET/PTC rearrangement in thyroid tumors.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more
  4 in total

1.  Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma.

Authors:  Masayo Shuto; Atsushi Seyama; Yoshiya Gotoh; Kouichi Kamada; Masaru Nakamura; Kenji Warigaya; Hiroshi Watanabe; Munehisa Ueno; Michio Shimizu; Toshio Fukuda; Shin-Ichi Murata
Journal:  Acta Histochem Cytochem       Date:  2012-01-24       Impact factor: 1.938

2.  Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.

Authors:  Tadao Nakazawa; Tetsuo Kondo; Ippei Tahara; Kazunari Kasai; Tomohiro Inoue; Naoki Oishi; Kunio Mochizuki; Takeo Kubota; Ryohei Katoh
Journal:  Cancer Med       Date:  2015-04-17       Impact factor: 4.452

3.  Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis.

Authors:  Xuan Su; Zhaoqu Li; Caiyun He; Weichao Chen; Xiaoyan Fu; Ankui Yang
Journal:  Oncotarget       Date:  2016-03-29

Review 4.  The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.

Authors:  Huy Gia Vuong; Ahmed M A Altibi; Amr Hesham Abdelhamid; Phuong Uyen Duong Ngoc; Vo Duy Quan; Mohamed Yousef Tantawi; Mohamed Elfil; Tran Le Huy Vu; Ahmed Elgebaly; Naoki Oishi; Tadao Nakazawa; Kenji Hirayama; Ryohei Katoh; Nguyen Tien Huy; Tetsuo Kondo
Journal:  Oncotarget       Date:  2017-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.